Last C$0.12 CAD
Change Today 0.00 / 0.00%
Volume 0.0
CHQ On Other Exchanges
Symbol
Exchange
Venture
OTC US
As of 10:41 AM 08/25/14 All times are local (Market data is delayed by at least 15 minutes).

carrus capital corp (CHQ) Snapshot

Open
C$0.12
Previous Close
C$0.12
Day High
C$0.12
Day Low
C$0.12
52 Week High
09/20/13 - C$0.35
52 Week Low
06/6/14 - C$0.11
Market Cap
243.9K
Average Volume 10 Days
366.0
EPS TTM
C$0.21
Shares Outstanding
2.0M
EX-Date
03/23/12
P/E TM
0.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for CARRUS CAPITAL CORP (CHQ)

Related News

No related news articles were found.

carrus capital corp (CHQ) Related Businessweek News

No Related Businessweek News Found

carrus capital corp (CHQ) Details

Carrus Capital Corporation engages in researching, developing, and commercializing drugs for the treatment of infectious diseases and other disease indications. The company’s products include Omigard that is in Phase III clinical trial for the prevention of catheter-related infections; and CLS-001, which is in Phase II clinical trial for the treatment of rosacea and other dermatological diseases. Its preclinical stage products comprise MX-2401 for the treatment of serious gram-positive bacterial infections; and SB-9000 for the treatment of hepatitis B virus infections. The company was formerly known as BioWest Therapeutics Inc. and changed its name to Carrus Capital Corporation in August 2011. The company was founded in 2004 and is based in Vancouver, Canada.

Founded in 2004

carrus capital corp (CHQ) Top Compensated Officers

Chief Executive Officer, Secretary, Director,...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: C$35.6K
Compensation as of Fiscal Year 2013.

carrus capital corp (CHQ) Key Developments

Carrus Capital Corporation, Annual General Meeting, Feb 25, 2014

Carrus Capital Corporation, Annual General Meeting, Feb 25, 2014., at 10:00 Pacific Standard Time. Agenda: To consider the audited financial statements of the company for the financial year ended April 30, 2013, together with the report of the auditors thereon; to fix the number of directors of the Company for the ensuing year at three; to elect directors of the company for the ensuing year; to appoint Smythe Ratcliffe LLP, as the auditors of the company for the ensuing year and to authorize the directors to fix the remuneration to be paid to the auditors for the ensuing year; to consider and, if thought fit, pass, with or without variation, a special resolution approving an arrangement under Division 5 of Part 9 of the Business Corporations Act which involves, among other things, the distribution to the Carrus Shareholders shares of BioAB Strategies Ltd., BioDE Ventures Ltd., and BioHEP Technologies Ltd; and to transact such other business as may properly come before the Meeting or at any adjournment(s) or postponement(s) thereof.

Carrus Capital Corporation Announces Executive Changes

Carrus Capital Corporation announced the appointment of Chester Shynkaryk and Donald Gordon to the Company's Board of Directors. Mr. Shynkaryk was the founding president of Golden Queen Mining Company Ltd. and Visionary Mining Corp. As an officer and Director, he has over 30 years of experience in junior public company management, promotion and finance. Mr. Gordon is the Vancouver representative for the Canadian National Stock Exchange, and has operated as an Independent Consultant to Investment Dealers conducting business assessments and to Issuers in a wide range of industries during the past 8 years. The Company also announced the resignation of Gregory Andrews and Douglas Johnson.

Carrus Capital Corporation, Annual General Meeting, Jan 15, 2014

Carrus Capital Corporation, Annual General Meeting, Jan 15, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHQ:CN C$0.12 CAD 0.00

CHQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CHQ.
View Industry Companies
 

Industry Analysis

CHQ

Industry Average

Valuation CHQ Industry Range
Price/Earnings 1.0x
Price/Sales 0.6x
Price/Book 0.5x
Price/Cash Flow 1.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARRUS CAPITAL CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.